Liver Cancer Drugs Market to Reach $1.35 Billion by 2015

The global liver cancer drugs market is expected to reach $1.35 billion by 2015, driven by the growing prevalence of liver cancer and the increasing adoption of targeted therapies. According to a new report, the market for liver cancer drugs will experience significant growth over the next few years, with the global market expected to expand at a compound annual growth rate (CAGR) of 10.1%.

Key Takeaways:

The global liver cancer drugs market is expected to reach $1.35 billion by 2015, growing at a CAGR of 10.1%.
The market is driven by the growing prevalence of liver cancer, which is expected to increase by 40% by 2025.
Targeted therapies, such as sorafenib and bevacizumab, are expected to dominate the market, accounting for over 60% of total market share.
The Asia-Pacific region is expected to be the fastest-growing market for liver cancer drugs, driven by increasing adoption of these treatments in China and Japan.
Companies such as 4SC AG, Actavis Group, Inc., and Pfizer Inc. are expected to be major players in the market, with proven track records of developing and marketing liver cancer treatments.
The market is also expected to be influenced by recent industry activity, including the approval of nexavar in regional markets and the increasing focus on personalized medicine.

Statistics:

The global liver cancer drugs market is expected to reach $1.35 billion by 2015, growing at a CAGR of 10.1%.
The market is expected to be driven by a 40% increase in liver cancer prevalence by 2025.
Targeted therapies are expected to account for over 60% of the market share by 2015.
The Asia-Pacific region is expected to grow from $100 million in 2009 to $255 million in 2015, at a CAGR of 21.4%.
The liver cancer market is expected to experience significant growth, with the global market expected to expand from $630 million in 2007 to $1.35 billion in 2015, at a CAGR of 10.1%.

Sources:

Research and Markets (http://www.researchandmarkets.com/research/a65c90/liver_cancer_drugs) - "Liver Cancer Drugs - Global Strategic Business Report"
Liver Cancer - Information (see also Liver Cancer)